J&J beats earnings estimates; Middle East conflict weighs on medical-device sales
Pharmaceutical sales jumped 7.7% in the quarter to $16.76 billion, but medical technology division sales rose just 2.5% to $8.6 billion.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results.
JPMorgan's Q3 adjusted EPS, revenue miss estimates
(This story was generated using AI and automation, please see disclaimer ) Overview U.S. banking giant's Q3 revenue rose 8% yr/yr but missed analyst expectations Adjusted EPS for Q3 missed analyst expectations Company reduced share repurchases this quarter Outlook Company says it remains prepared for a wide range of ec